⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18529401 | 1.00 | — | — | |
| SCHEMBL1190904 | 1.00 | — | — | |
| SCHEMBL11249691 | 0.79 | — | — | |
| SCHEMBL11249689 | 0.79 | — | — | |
| SCHEMBL17764763 | 0.78 | TSHR (0.33) | — | |
| SCHEMBL109549 | 0.78 | TSHR (0.33) | — | |
| SCHEMBL109550 | 0.78 | TSHR (0.33) | — | |
| SCHEMBL5985957 | 0.78 | — | — | |
| SCHEMBL5985953 | 0.78 | — | — | |
| SCHEMBL29045303 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114126606-B | Method for dispersing a biofilm comprising gram-negative bacteria | Q生物股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-116693603-A | Bicyclic fused compounds for the treatment of inflammatory diseases and uses thereof | 南京知和医药科技有限公司 | 2023-09-05 | — | — | CN | disclosed |
| US-20230250218-A1 | URETHANE COMPOSITION | NITTO KASEI CO., LTD. (JP) | 2023-08-10 | — | — | US | disclosed |
| EP-4198068-A1 | URETHANE COMPOSITION | Nitto Kasei Co., Ltd. (JP) | 2023-06-21 | — | — | EP | disclosed |
| WO-2023088308-A1 | ANTIMICROBIAL COMPOUND HAVING ANTI-DRUG RESISTANCE | 石家庄迪斯凯威医药科技有限公司 | 2023-05-25 | — | — | WO | disclosed |
| CN-116135871-A | Antibacterial compound with drug resistance | 石家庄迪斯凯威医药科技有限公司 | 2023-05-19 | — | — | CN | disclosed |
| CN-116018365-A | Carbamate composition | 日东化成株式会社 | 2023-04-25 | — | — | CN | disclosed |
| EP-3986394-A1 | BIOFILM DISRUPTION | QBiotics Pty Ltd (AU) | 2022-04-27 | — | — | EP | disclosed |
| CN-114126606-A | Photocurable composition with variable viscosity | Q生物股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| WO-2020252535-A1 | BIOFILM DISRUPTION | QBiotics Pty Ltd (AU) | 2020-12-24 | — | — | WO | disclosed |
| US-4755598-A | 1'-(substituted)ethyl-7β-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylate derivatives having antibacterial utility | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1988-07-05 | — | — | US | disclosed |
| US-4730044-A | Sparsomycin derivatives | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-03-08 | — | — | US | disclosed |
| US-4714706-A | JUVENILE HORMONE INHIBITORS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-12-22 | — | — | US | disclosed |
| EP-0236510-A1 | PROSTACYCLINS AND DRUGS CONTAINING THE SAME | MITSUBISHI KASEI CORPORATION (JP) | 1987-09-16 | — | — | EP | disclosed |
| EP-0234158-A1 | (2-Chloro-3-oxo-1-alkenyl)bicyclo (3.3.0.) octene derivative and process for preparing the same | MITSUBISHI KASEI CORPORATION (JP) | 1987-09-02 | — | — | EP | disclosed |
| EP-0234576-A1 | Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1987-09-02 | — | — | EP | disclosed |
| EP-0203798-A2 | Nitrogen-containing heterocyclic compounds, and their production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-12-03 | — | — | EP | disclosed |
| US-4595687-A | Sparsomycin derivatives | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-06-17 | — | — | US | disclosed |
| EP-0168813-A1 | Sparsomycin derivatives | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-01-22 | — | — | EP | disclosed |
| EP-0128028-A2 | Cephalosporin derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1984-12-12 | — | — | EP | disclosed |